Paper41753172
Predicting the Unpredictable: Prognostic Role of Systemic Inflammatory Indices and Tumor Biology of Neoadjuvant Chemotherapy Response in Gastric and Gastroesophageal Junction Cancer-Insights from a Systematic Review and Real-World Experience.
Oyucu Orhan S and 9 others. J Clin Med, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Predicting the Unpredictable: Prognostic Role of Systemic Inflammatory Indices and Tumor Biology of Neoadjuvant Chemotherapy Response in Gastric and Gastroesophageal Junction Cancer-Insights from a Systematic Review and Real-World Experience. Papers, record 41753172. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41753172
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Predicting the Unpredictable: Prognostic Role of Systemic Inflammatory Indices and Tumor Biology of Neoadjuvant Chemotherapy Response in Gastric and Gastroesophageal Junction Cancer-Insights from a Systematic Review and Real-World Experience.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References33
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37755563 | Patterns of Recurrence After Poor Response to Neoadjuvant Chemotherapy in Gastric Cancer and the Role for Adjuvant Radiation. | Ann Surg Oncol | 2024 | https://conductscience.org/library/papers/37755563 | PubMed |
| 2 | 37077865 | Impact of neoadjuvant FLOT treatment of advanced gastric and gastroesophageal junction cancer following surgical therapy. | Front Surg | 2023 | https://conductscience.org/library/papers/37077865 | PubMed |
| 3 | 32269843 | Association between Lymphovascular Invasion and Recurrence in Patients with pT1N+ or pT2-3N0 Gastric Cancer: a Multi-institutional Dataset Analysis. | J Gastric Cancer | 2020 | https://conductscience.org/library/papers/32269843 | PubMed |
| 4 | 21444866 | Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. | J Clin Oncol | 2011 | https://conductscience.org/library/papers/21444866 | PubMed |
| 5 | 41055838 | FLOT vs DOS neoadjuvant chemotherapy in locally advanced gastric cancer: propensity score analysis. | Int J Clin Oncol | 2025 | https://conductscience.org/library/papers/41055838 | PubMed |
| 6 | 12401408 | Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. | Trends Immunol | 2002 | https://conductscience.org/library/papers/12401408 | PubMed |
| 7 | 35579894 | Real life experience of patients with locally advanced gastric and gastroesophageal junction adenocarcinoma treated with neoadjuvant chemotherapy: a Turkish oncology group study. | J Chemother | 2023 | https://conductscience.org/library/papers/35579894 | PubMed |
| 8 | 37435205 | Perioperative versus total neoadjuvant chemotherapy in gastric cancer. | J Gastrointest Oncol | 2023 | https://conductscience.org/library/papers/37435205 | PubMed |
| 9 | 21360132 | The effectiveness of the new (7th) UICC N classification in the prognosis evaluation of gastric cancer patients: a comparative study between the 5th/6th and 7th UICC N classification. | Gastric Cancer | 2011 | https://conductscience.org/library/papers/21360132 | PubMed |
| 10 | 35914639 | Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. | Ann Oncol | 2022 | https://conductscience.org/library/papers/35914639 | PubMed |
| 11 | 34252374 | Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial. | Lancet Oncol | 2021 | https://conductscience.org/library/papers/34252374 | PubMed |
| 12 | 37119707 | Prognostic value of [18F]FDG PET/CT on treatment response and progression-free survival of gastroesophageal cancer patients undergoing perioperative FLOT chemotherapy. | Eur J Radiol | 2023 | https://conductscience.org/library/papers/37119707 | PubMed |
| 13 | 30982686 | Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial. | Lancet | 2019 | https://conductscience.org/library/papers/30982686 | PubMed |
| 14 | 22646630 | Preoperative chemoradiotherapy for esophageal or junctional cancer. | N Engl J Med | 2012 | https://conductscience.org/library/papers/22646630 | PubMed |
| 15 | 31832860 | The ratio of hemoglobin to red cell distribution width predicts survival in patients with gastric cancer treated by neoadjuvant FLOT: a retrospective study. | Ir J Med Sci | 2020 | https://conductscience.org/library/papers/31832860 | PubMed |
| 16 | 40454643 | Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer. | N Engl J Med | 2025 | https://conductscience.org/library/papers/40454643 | PubMed |
| 17 | 40250473 | Do Nutritional and Inflammatory Indices Predict Response in Geriatric Gastric Cancer Patients Treated with Neoadjuvant FLOT Regimen? | Cancer Control | 2025 | https://conductscience.org/library/papers/40250473 | PubMed |
| 18 | 39400342 | The New Era of Total Neoadjuvant FLOT Therapy for Locally Advanced, Resectable Gastric Cancer: A Propensity-Matched Comparison With Standard Perioperative Therapy. | J Surg Oncol | 2025 | https://conductscience.org/library/papers/39400342 | PubMed |
| 19 | 37836440 | Pretreatment Modified Glasgow Prognostic Score for Predicting Prognosis and Survival in Elderly Patients with Gastric Cancer Treated with Perioperative FLOT. | Nutrients | 2023 | https://conductscience.org/library/papers/37836440 | PubMed |
| 20 | 28918544 | Tumor regression grading of gastrointestinal cancers after neoadjuvant therapy. | Virchows Arch | 2018 | https://conductscience.org/library/papers/28918544 | PubMed |
Genes13
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41753172
GET https://conductscience.org/api/papers/v1/41753172/references?page=2